[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2004, 30(6) 339-341 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
��ƽ̦޺
����
���������������
���
����
PubMed
Article by
Article by

��ƽ̦޺�����ƽ�չ

���, ����

�㽭��ѧҽѧԺ������һҽԺƤ���� ���� 310003

ժҪ��

��ƽ̦޺��һ��ԭ�������Ǽ��Ի�������֢��Ƥ�������Ŵ����ء��������ߡ���Ⱦ�����������ء�ҩ�����صȿ��ܺͼ�����ء�������������Ƥ�ʼ���Ϊ��,���ܶ໼�����Ƶֿ�,����һЩ�Ĥ�����͵����Ƥ��,���׷�����������������A������Ī˾��άA�ᡢ�����ߡ��ͷ��������ص����ƴ�ʩ���ٴ���ȡ����һ������Ч��

�ؼ����� ��ƽ̦޺   ����  

Abstract:

Keywords:
�ո����� 2004-02-04 �޻�����  ����淢������  
DOI:
������Ŀ:

ͨѶ����: ����,E-mail:Fang��ongzy@sina.com
���߼��:

�ο����ף�
[1] McCreary CE, McCartan BE. Clinical management of oral lichen planus. Br J Oral Maxillofac Surg, 1999,37:338-343.
[2] Carrozzo M, Gandolfo S. The management of oral lichen planus. Oral Dis, 1999,5:196-205.
[3] Bernstein ML. The diagnosis and management of chronic nonspecific mucosal lesions. J Calif Dent Assoc, 1999,27:290-299.
[4] Carbone M, Conrotto D, Carrozzo M, et al. Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Dis,1999,5:44-49.
[5] Anderson M, Kutzner S, Kaufman RH. Treatment of vulvovaginal lichen planus with vaginal hydrocortisone suppositories. Obstet Gynecol,2002,100:359-362.
[6] yon Krogh G, Dahlman-Ghozlan K, Syrjanen S. Potential human papillomavirus reactivation following topical corticosteroid therapy of genital lichen sclerosus and erosive lichen planus. J Eur Acad Dermatol Venereol, 2002,16:130-133.
[7] Liu ZW, Lin TN, He GZ. Research of compound cyclosporin A mouthwash in the treatment of oral lichen planus. Hunan Yi Ke Da Xue Xue Bao, 2000,25:183-184.
[8] Rozycki TW, Rogers RS 3rd, Pittelkow MR, et al. Topical tacrolimus in the treatment of symptomatic oral lichen planus: a series of 13 patients. J Am Acad Dermatol, 2002,46:27-34.
[9] Kaliakatsou F, Hodgson TA, Lewsey JD,et al. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol, 2002,46:35-41.
[10] Olivier V, Lacour JP, Mousnier A, et al. Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study. Arch Dermatol, 2002,138:1335-1338.
[11] Laurberg G, Geiger JM, Hjorth N, et al. Treatment of lichen planus with acitretin. A double-blind, placebo-controlled study in 65 patients. J Am Acad Dermatol, 1991,24:434-437.
[12] Ott F, Bollag W, Geiger JM. Efficacy of oral low-dose tretinoin (alltrans-retinoic acid) in lichen planus. Dermatology, 1996,192:334-336.
[13] Boisnic S, Branchet MC, Pascal F,et al. Topical tretinoin in the treatment of lichen planus and leukoplakia of the mouth mucosa. A clinical evaluation. Ann Dermatol Venereol, 1994,121:459-463.
[14] Lehtinen R, Happonen RP, Kuusilehto A,et al. A clinical trial of PUVA treatment in oral lichen planus. Proc Finn Dent Soc, 1989,85:29-33.
[15] Kuusilehto A, Lehtinen R, Happonen RP, et al. An open clinical trial of a new mouth-PUVA variant in the treatment of oral lichenoid lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1997,84:502-505.
[16] Lundquist G, Forsgren H, Gajecki M,et al. Photochemotherapy of oral lichen planus. A controlled study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1995,79:554-558.
[17] Reichrath J, Reinhold U, Tilgen W. Treatment of genito-anal lesions in inflammatory skin diseases with PUVA cream photochemotherapy:an open pilot study in 12 patients. Dermatology,2002,205:245-248.
[18] Carlin CS, Florell SR, Krueger GG. Induction of dramatic hyperpigmentation in a patient with generalized lichen planus treated with rePUVA. J Cutan Med Surg, 2002,6:125-127.
[19] Taneja A, Taylor CR. Narrow-band UVB for lichen planus treatment.Int J Dermatol, 2002,41:282-283.
[20] Hodak E, Yosipovitch G, David M, et al. Low-dose low-molecularweight heparin (enoxaparin) is beneficial in lichen planus: a preliminary report. J Am Acad Dermatol, 1998,38:564-568.
[21] Stefanidou MP, Ioannidou DJ, Panayiotides JG, et al. Low molecular weight heparin; a novel alternative therapeutic approach for lichen planus. Br J Dermatol, 1999,141:1040-1045.
[22] Pacheco H, Kerdel F. Successful treatment of lichen planus with lowmolecular-weight heparin: a case series of seven patients. J Dermatolog Treat, 2001,12:123-126.
[23] El-Serag HB, Hampel H, Yeh C, et al. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology, 2002,36:1439-1445.
[24] Nagao Y, Sata M, Ide T, et al. Development and exacerbation of oral lichen planus during and after interferon therapy for hepatitis C. Eur J Clin Invest, 1996,26:1171-1174.
[25] Bayram gurler D, Apaydin R, Bilen N. Limited benefit of topical calcipotriol in lichen planus treatment: a preliminary study. J Dermatolog Treat,2002, 13:129-132.
[26] Bouloc A, Revuz J, Bagot M, et al. KH 1060 for the treatment of lichen planus: a multicenter, randomized, double-blind, vehicle-controlled study. Arch Dermatol, 2000,136:1272.
�������������
1����ѧ�� ���� ��Ƽ �Ŵ�.�����崯����ƽ̦޺һ��[J]. ����Ƥ���Բ�ѧ��־, 2010,36(2): 114-114
2����������, ����Ӣ��У.�����崯����ƽ̦޺[J]. ����Ƥ���Բ�ѧ��־, 1994,20(5): 276-278
3������������, ֣������У.��ƽ̦޺������[J]. ����Ƥ���Բ�ѧ��־, 1995,21(1): 1-4
4���ƶ�������, ����Ӣ��У.��ǻ��ƽ̦޺[J]. ����Ƥ���Բ�ѧ��־, 1995,21(5): 270-273
5���ƶ�������, ����Ӣ��У.��ƽ̦޺�о���ijЩ�½�չ[J]. ����Ƥ���Բ�ѧ��־, 1996,22(4): 200-202
6����һԪ����, ��������У.��ƽ̦޺��̦޺����IJ���Ͳ�������[J]. ����Ƥ���Բ�ѧ��־, 1998,24(5): 292-295
7������ ���tȺ �Ź��� ��Ծƽ.ɫ���Ա�ƽ̦޺һ��[J]. ����Ƥ���Բ�ѧ��־, 2014,40(6): 407-407

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־